In focus
Latest feed
BridgeBio's Attruby Appears to Outshine Pfizer's Vyndamax in Crucial Real-World Study for ATTR-CM
Big Win for Pfizer: Appeals Court Upholds Key Patent Against Enanta in Hepatitis C Battle
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
Closing Bell Insights: Navigating Pfizer, Agribusiness, and Gold Miners as the Market Winds Down
